X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Emami Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs EMAMI LTD - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES EMAMI LTD AMAR REMEDIES/
EMAMI LTD
 
P/E (TTM) x -0.5 90.2 - View Chart
P/BV x 0.1 16.3 0.4% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 AMAR REMEDIES   EMAMI LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
EMAMI LTD
Mar-17
AMAR REMEDIES/
EMAMI LTD
5-Yr Chart
Click to enlarge
High Rs1641,260 13.0%   
Low Rs86916 9.4%   
Sales per share (Unadj.) Rs261.6109.8 238.2%  
Earnings per share (Unadj.) Rs17.415.0 116.1%  
Cash flow per share (Unadj.) Rs22.328.6 78.0%  
Dividends per share (Unadj.) Rs07.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs100.777.3 130.3%  
Shares outstanding (eoy) m26.16226.97 11.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.59.9 4.8%   
Avg P/E ratio x7.272.6 9.9%  
P/CF ratio (eoy) x5.638.1 14.7%  
Price / Book Value ratio x1.214.1 8.8%  
Dividend payout %046.7 0.0%   
Avg Mkt Cap Rs m3,270246,898 1.3%   
No. of employees `000NA3.1 0.0%   
Total wages/salary Rs m1632,336 7.0%   
Avg. sales/employee Rs ThNM8,049.9-  
Avg. wages/employee Rs ThNM754.1-  
Avg. net profit/employee Rs ThNM1,097.8-  
INCOME DATA
Net Sales Rs m6,84424,930 27.5%  
Other income Rs m21311 6.8%   
Total revenues Rs m6,86525,241 27.2%   
Gross profit Rs m1,1317,591 14.9%  
Depreciation Rs m1283,086 4.1%   
Interest Rs m398580 68.6%   
Profit before tax Rs m6264,236 14.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121836 14.5%   
Profit after tax Rs m4553,400 13.4%  
Gross profit margin %16.530.4 54.3%  
Effective tax rate %19.319.7 97.9%   
Net profit margin %6.613.6 48.7%  
BALANCE SHEET DATA
Current assets Rs m4,9044,579 107.1%   
Current liabilities Rs m3,5817,776 46.1%   
Net working cap to sales %19.3-12.8 -150.8%  
Current ratio x1.40.6 232.5%  
Inventory Days Days12426 473.7%  
Debtors Days Days10014 705.2%  
Net fixed assets Rs m1,6897,633 22.1%   
Share capital Rs m262227 115.4%   
"Free" reserves Rs m2,35817,320 13.6%   
Net worth Rs m2,63517,547 15.0%   
Long term debt Rs m5070-   
Total assets Rs m6,86226,127 26.3%  
Interest coverage x2.68.3 31.0%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.0 104.5%   
Return on assets %12.415.2 81.6%  
Return on equity %17.319.4 89.1%  
Return on capital %31.027.4 112.9%  
Exports to sales %4.02.9 136.1%   
Imports to sales %00-   
Exports (fob) Rs m273731 37.4%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273911 30.0%   
Fx outflow Rs m2468 0.4%   
Net fx Rs m271443 61.2%   
CASH FLOW
From Operations Rs m-3137,296 -4.3%  
From Investments Rs m-489-2,975 16.4%  
From Financial Activity Rs m769-4,958 -15.5%  
Net Cashflow Rs m-33-721 4.5%  

Share Holding

Indian Promoters % 25.5 70.6 36.1%  
Foreign collaborators % 0.0 2.2 -  
Indian inst/Mut Fund % 9.2 1.3 707.7%  
FIIs % 0.0 16.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 9.2 709.8%  
Shareholders   13,061 25,076 52.1%  
Pledged promoter(s) holding % 99.7 19.5 511.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   RELAXO FOOTWEARS  GODREJ INDUSTRIES  COLGATE  MARICO LTD  K.S.OILS LTD  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Of Sensex Touching Record Highs, Rally in Banking Stocks and Key Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,000 on Wednesday and further inched upwards to end yesterday's trade at a level of 35,260.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS